RAPHARM
Business purpose.
La Société a pour objet, conformément à l'article 31-1 de la loi du 31 décembre 1990, la détention de parts ou d'actions de sociétés d'exercice libéral (SEL) (sous forme de société à responsabilité limitée, société anonyme, société par actions simplifiée, ou de sociétés en commandite par actions) ayant pour objet l'exercice de la profession de pharmacien d'officine, ainsi que la participation à tout groupement de droit étranger ayant pour objet l'exercice de la même profession. Et plus généralement la prise de participation dans toute société ou groupement ou personne morale dans la limite ce qui est autorisé par la loi et les dispositions régissant son activité.
Identity
- Legal form
- SPFPL holding company for regulated professions, as an SAS (SPFPL SAS)
- Activity
- Activities of holding companies (64.20Z)
- Sector
- Financial service activities, except insurance and pension funding
- Headcount
- Headcount unknown
- Created
- 6 May 2023
- Share capital
- 1,000.00 EUR
- Establishments
- 1
Directors
- Raphaël CHICHEPORTICHE 32 years old, 09/1994 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- PHARMACIE MARSOULAN via Raphaël CHICHEPORTICHE
Establishments
Financial strength
Financial score
30 / 100 E
Confidence: medium · computed on the financial year ended 31 Dec 2025
- Equity to assets (-7.4 %)
- 2.3 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (66.5 %)
- 1.9 out of 20
- Debt (-1,177.8 %)
- 15.0 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
87 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (3.4 years)
- 6.9 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 0 € | — | -2,966 € | -20,410 € |
| 31 Dec 2024 | 0 € | — | -2,418 € | -21,174 € |
| 31 Dec 2023 | 0 € | first year on record | -23,168 € | -23,174 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Filing of accounts 21 Jul 2026
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260136, annonce n 13708 · Proof of publication (PDF)
-
Filing of accounts 3 Aug 2025
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250147, annonce n 8727 · Proof of publication (PDF)
-
Filing of accounts 11 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240133, annonce n 16282 · Proof of publication (PDF)
Filings and accounts
- Formality 26 Apr 2023
Change history
- officer_appointed (empty) → President de SAS 5 Oct 2026